The tissue-specific metabolic effects of the PPARalpha agonist ciprofibrate in insulin-resistant male individuals: a double-blind, randomized, placebo-controlled crossover study

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: de Wit-Verheggen, V. H. W., Vanweert, F., Raiko, J., Lienard, V., Schaart, G., Gemmink, A., Nascimento, E. B. M., Hesselink, M. K. C., Wildberger, J. E., Wierts, R., Joris, P. J., Haas, J., Montaigne, D., Staels, B., Phielix, E., Schrauwen, P., Schrauwen-Hinderling, V. B., van de Weijer, T.

Journal title: Obesity

Journal publisher: Obesity

Published year: 2023

DOI identifier: 10.1002/oby.23874

ISSN: 1930-739X